Search results
AbbVie (ABBV) Beats Stock Market Upswing: What Investors Need to Know
AbbVie (ABBV) closed at $256.18 in the latest trading session, marking a +1.11% move from the prior day. The stock's performance was ahead of the S&P 500's daily gain of 0.89%. Elsewhere, the Dow
AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects AbbVie (ABBV) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is
AbbVie (ABBV) Q2 Earnings and Revenues Beat Estimates
AbbVie (ABBV) came out with quarterly earnings of $3.65 per share, beating the Zacks Consensus Estimate of $3.64 per share. This compares to earnings of $2.97 per share a year ago. These figures are
AbbVie (ABBV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended June 2026, AbbVie (ABBV) reported revenue of $16.99 billion, up 10.2% over the same period last year. EPS came in at $3.65, compared to $2.97 in the year-ago quarter.
The
Will AbbVie's Oncology Franchise Remain Under Pressure in Q2?
AbbVie’s ABBV oncology franchise has evolved considerably in recent years. What was once largely a hematology-focused business has expanded into solid tumors through a series of acquisitions
Should You Buy, Hold or Sell ABBV Stock Ahead of Q2 Earnings?
AbbVie ABBV is set to report second-quarter 2026 earnings on July 31, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s sales is pinned at $16.81 billion, while
ABBV Beats on Q2 Earnings & Sales, Cuts '26 EPS View, Stock Down
AbbVie ABBV reported second-quarter 2026 adjusted EPS of $3.65, which beat the Zacks Consensus Estimate of $3.64. The reported figure also exceeded the company’s guidance of $3.57-$3.61 per share
ABB Aktie: Auftragseingang springt um 30 Prozent
ABB hat am 16. Juli 2026 Quartalszahlen vorgelegt, die in mehrfacher Hinsicht Rekordniveau markieren.…
Der Beitrag ABB Aktie: Auftragseingang springt um 30 Prozent erschien zuerst auf kapitalmarktex
AbbVie Aktie: RINVOQ punktet doppelt
Zwei EU-Zulassungen an einem Tag — das gab es für AbbVie selten. Die Europäische…
Der Beitrag AbbVie Aktie: RINVOQ punktet doppelt erschien zuerst auf kapitalmarktexperten.de.
Quelle kapitalmarktexp
AbbVie Q2 Earnings Call Highlights
Key Points
- Interested in AbbVie Inc.? Here are five stocks we like better.
- AbbVie exceeded Q2 expectations, reporting nearly $17 billion in revenue, up 10.2% year over year, and adjusted EPS of
ABB Aktie: 503 Pence für Rotork
Juli 2026 Zahlen vorgelegt, die die Erwartungen deutlich übertreffen. Umsatz und Auftragseingang legten kräftig…
Der Beitrag ABB Aktie: 503 Pence für Rotork erschien zuerst auf kapitalmarktexperten.
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Is Abbott Stock Attractive After Its Earnings and Guidance Update?
Abbott Laboratories ABT has a stronger earnings setup after a second-quarter beat and a higher profit outlook. The question is whether that improvement is enough to justify buying the stock with
Abbott Rides Key Diabetes, Oncology and Heart Care Innovation Trends
Abbott Laboratories ABT is leaning into three of healthcare’s most durable innovation themes: continuous glucose monitoring, oncology diagnostics and advanced cardiovascular treatment. These areas
SpaceX Aktie: 69 Gasturbinen bis Juli 2027 abbauen
SpaceX-Aktien rutschen weiter ab. Am Freitag schloss das Papier bei 93,96 Euro, ein Minus…
Der Beitrag SpaceX Aktie: 69 Gasturbinen bis Juli 2027 abbauen erschien zuerst auf kapitalmarktexperten.de.
